Works matching IS 17762596 AND DT 2025 AND VI 20 AND IP 3

Results: 12

Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 445, doi. 10.1007/s11523-025-01146-4

By:

Saad, Fred;
Armstrong, Andrew J.;
Shore, Neal;
George, Daniel J.;
Oya, Mototsugu;
Sugimoto, Mikio;
McKay, Rana R.;
Hussain, Maha;
Clarke, Noel W.

Publication type:

Article

Efficacy of First-Line Treatments for Advanced Renal Cell Carcinoma: A Bayesian Network Meta-analysis of Objective Response, Progression-Free Survival, and Overall Survival.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 375, doi. 10.1007/s11523-025-01147-3

By:

Schmidinger, Manuela;
Rane, Pratik P.;
Yan, Kevin;
Druyts, Eric;
Burgents, Joseph;
Sundaram, Murali;
Peer, Avivit

Publication type:

Article

Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 531, doi. 10.1007/s11523-025-01144-6

By:

Morimoto, Kenji;
Yamada, Tadaaki;
Furuya, Naoki;
Tanaka, Hisashi;
Yoshimura, Akihiro;
Oba, Tomohiro;
Hibino, Makoto;
Fukuda, Takahito;
Goto, Yasuhiro;
Nakao, Akira;
Ogusu, Shinsuke;
Okazaki, Yuta;
Harada, Taishi;
Ota, Takayo;
Masubuchi, Ken;
Mikami, Koji;
Hata, Tae;
Matsumoto, Shoki;
Honda, Ryoichi;
Date, Koji

Publication type:

Article

Potential Mechanisms for Immunotherapy Resistance in Adult Soft-Tissue Sarcoma.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 485, doi. 10.1007/s11523-025-01145-5

By:

Kret, Zaina S.;
Sweder, Ryan J.;
Pollock, Raphael;
Tinoco, Gabriel

Publication type:

Article

Immunotherapy for Renal Cell Carcinoma—What More is to Come?

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 467, doi. 10.1007/s11523-025-01143-7

By:

Yochum, Zachary A.;
Braun, David A.

Publication type:

Article

The Impact of Uncommon HRR Alterations as Predictors of Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 405, doi. 10.1007/s11523-025-01141-9

By:

Pinterpe, Giada;
Migliaccio, Fortuna;
Ciccarese, Chiara;
Pedone, Romina Rose;
Belletto, Rachele;
Russo, Pierluigi;
Totaro, Angelo;
Tagliaferri, Luca;
Sighinolfi, Chiara;
Formisano, Luigi;
Berardi, Rossana;
Rocco, Bernardo;
Tortora, Giampaolo;
Iacovelli, Roberto

Publication type:

Article

Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysis.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 389, doi. 10.1007/s11523-025-01142-8

By:

Akkus, Erman;
Yasar, Hatime Arzu;
Rimassa, Lorenza;
Lamarca, Angela

Publication type:

Article

Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 503, doi. 10.1007/s11523-025-01139-3

By:

De La Cerda, Jose;
Belkoff, Laurence;
Courtney, Kevin D.;
Diamond, Elan;
D'Olimpio, James;
Dunshee, Curtis;
Gervasi, Lawrence;
Goodman, Michael;
Mittal, Kriti;
Morris, David;
Sieber, Paul;
Tutrone, Ronald;
Ryan, Michael;
Zhong, Yi;
Ufer, Mike;
Shore, Neal

Publication type:

Article

Navigating the Landscape of Resistance Mechanisms in Antibody–Drug Conjugates for Cancer Treatment.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 419, doi. 10.1007/s11523-025-01140-w

By:

Lalli, Gloria;
Sabatucci, Ilaria;
Paderno, Mariachiara;
Martinelli, Fabio;
Signorelli, Mauro;
Maruccio, Matteo;
Di Martino, Giampaolo;
Fucà, Giovanni;
Lorusso, Domenica

Publication type:

Article

A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 519, doi. 10.1007/s11523-025-01130-y

By:

Eng, Cathy;
Lakhani, Nehal J.;
Philip, Philip A.;
Schneider, Charles;
Johnson, Benny;
Kardosh, Adel;
Chao, Mark P.;
Patnaik, Amita;
Shihadeh, Fadi;
Lee, Yeonju;
Song, Kai;
Jin, Denise;
Huo, Yanan;
Howland, Michael;
Fisher, George A.;
Hecht, J. Randolph

Publication type:

Article

PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor–Positive Advanced Breast Cancer.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 431, doi. 10.1007/s11523-025-01137-5

By:

Hamilton, Erika P.;
Jeselsohn, Rinath M.;
Vahdat, Linda T.;
Hurvitz, Sara A.

Publication type:

Article

CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant—A Podcast.

Published in:

Targeted Oncology, 2025, v. 20, n. 3, p. 371, doi. 10.1007/s11523-025-01129-5

By:

de Lima, Marcos;
Marks, David I.

Publication type:

Article